相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Predictors of Subsequent Heart Failure After Left Atrial Appendage Closure
Dae-Young Kim et al.
CIRCULATION JOURNAL (2022)
Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation
Laurent Fauchier et al.
STROKE (2022)
Association of heart failure with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the national inpatient sample of 62 980 procedures
Muhammad Bilal Munir et al.
EUROPACE (2022)
Utilization and procedural adverse outcomes associated with Watchman device implantation
Fouad Khalil et al.
EUROPACE (2021)
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study
Antonio Creta et al.
EUROPACE (2021)
Left Atrial Appendage Closure for Primary and Secondary Stroke Prevention in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Pilot Study
Bin-Feng Mo et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
Richard P. Whitlock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Racial disparities in patients diagnosed with light chain (AL) amyloidosis
Anita D'Souza et al.
BLOOD CANCER JOURNAL (2021)
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update
Michael Glikson et al.
EUROPACE (2020)
Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
Ethan J. Rowin et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Craig T. January et al.
CIRCULATION (2019)
Estimates and Temporal Trend for US Nationwide 30-Day Hospital Readmission Among Patients With Ischemic and Hemorrhagic Stroke
Arvind B. Bambhroliya et al.
JAMA NETWORK OPEN (2018)
Thirty-Day Readmissions After Endovascular or Surgical Therapy for Critical Limb Ischemia Analysis of the 2013 to 2014 Nationwide Readmissions Databases
Dhaval Kolte et al.
CIRCULATION (2017)
Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA)
Oliver P. Guttmann et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work
Steven R. Austin et al.
MEDICAL CARE (2015)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High-Risk Population
Konstantinos C. Siontis et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy
Tomoko Tani et al.
CARDIOVASCULAR ULTRASOUND (2011)
Management of cocaine-associated chest pain and myocardial infarction - A scientific statement from the American heart association acute cardiac care committee of the council on clinical cardiology
James McCord et al.
CIRCULATION (2008)
Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy
I Olivotto et al.
CIRCULATION (2001)